Nature's Sunshine Products Gross Margin 2012-2026 | NATR

Current and historical gross margin for Nature's Sunshine Products (NATR) over the last 10 years. The current gross profit margin for Nature's Sunshine Products as of June 30, 2026 is %.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Nature's Sunshine Products Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2026-06-30 $0.49B $0.36B 73.17%
2026-03-31 $0.49B $0.36B 72.65%
2025-12-31 $0.48B $0.35B 72.50%
2025-09-30 $0.47B $0.34B 72.36%
2025-06-30 $0.46B $0.33B 71.80%
2025-03-31 $0.46B $0.33B 71.77%
2024-12-31 $0.46B $0.33B 71.43%
2024-09-30 $0.45B $0.32B 71.30%
2024-06-30 $0.44B $0.32B 71.72%
2024-03-31 $0.45B $0.32B 72.10%
2023-12-31 $0.45B $0.32B 71.97%
2023-09-30 $0.44B $0.32B 72.05%
2023-06-30 $0.43B $0.31B 71.66%
2023-03-31 $0.42B $0.30B 71.50%
2022-12-31 $0.42B $0.30B 71.09%
2022-09-30 $0.44B $0.31B 71.62%
2022-06-30 $0.45B $0.32B 72.26%
2022-03-31 $0.45B $0.33B 72.79%
2021-12-31 $0.44B $0.33B 73.87%
2021-09-30 $0.43B $0.32B 73.83%
2021-06-30 $0.41B $0.30B 73.61%
2021-03-31 $0.39B $0.29B 73.40%
2020-12-31 $0.39B $0.28B 73.51%
2020-09-30 $0.38B $0.28B 73.60%
2020-06-30 $0.36B $0.27B 73.90%
2020-03-31 $0.37B $0.27B 73.91%
2019-12-31 $0.36B $0.27B 74.10%
2019-09-30 $0.37B $0.27B 74.18%
2019-06-30 $0.37B $0.27B 74.18%
2019-03-31 $0.37B $0.27B 74.18%
2018-12-31 $0.36B $0.27B 74.18%
2018-09-30 $0.36B $0.26B 73.80%
2018-06-30 $0.36B $0.26B 73.80%
2018-03-31 $0.35B $0.26B 73.91%
2017-12-31 $0.34B $0.25B 73.61%
2017-09-30 $0.34B $0.25B 73.29%
2017-06-30 $0.33B $0.25B 73.57%
2017-03-31 $0.34B $0.25B 73.61%
2016-12-31 $0.34B $0.25B 73.53%
2016-09-30 $0.34B $0.25B 73.81%
2016-06-30 $0.33B $0.24B 73.41%
2016-03-31 $0.32B $0.24B 73.37%
2015-12-31 $0.33B $0.24B 73.54%
2015-09-30 $0.33B $0.24B 73.49%
2015-06-30 $0.35B $0.26B 74.20%
2015-03-31 $0.36B $0.27B 74.51%
2014-12-31 $0.37B $0.28B 75.14%
2014-09-30 $0.37B $0.28B 75.96%
2014-06-30 $0.37B $0.28B 75.62%
2014-03-31 $0.37B $0.28B 75.68%
2013-12-31 $0.37B $0.28B 75.34%
2013-09-30 $0.37B $0.27B 74.86%
2013-06-30 $0.37B $0.27B 74.79%
2013-03-31 $0.36B $0.27B 74.73%
2012-12-31 $0.36B $0.27B 74.52%
2012-09-30 $0.37B $0.26B 71.00%
2012-06-30 $0.37B $0.27B 72.63%
2012-03-31 $0.37B $0.27B 74.18%
2011-12-31 $0.37B $0.28B 75.54%
2011-09-30 $0.37B $0.28B 75.14%
2011-06-30 $0.36B $0.27B 74.79%
2011-03-31 $0.36B $0.27B 74.44%
2010-12-31 $0.35B $0.26B 74.29%
2010-09-30 $0.35B $0.28B 79.94%
2010-06-30 $0.35B $0.28B 79.66%
2010-03-31 $0.35B $0.28B 79.77%
2009-12-31 $0.34B $0.27B 79.82%
2009-09-30 $0.34B $0.27B 79.71%
2009-06-30 $0.35B $0.28B 80.40%
2009-03-31 $0.36B $0.29B 80.78%
2008-12-31 $0.37B $0.30B 80.91%
2008-09-30 $0.37B $0.30B 80.97%
2008-06-30 $0.37B $0.30B 80.43%
2008-03-31 $0.36B $0.29B 80.44%
2007-12-31 $0.36B $0.29B 80.33%
2007-09-30 $0.36B $0.29B 79.40%
2007-06-30 $0.36B $0.29B 79.67%
2007-03-31 $0.36B $0.29B 79.72%
2005-12-31 $0.35B $0.28B 80.68%
2005-09-30 $0.34B $0.28B 81.98%
2005-06-30 $0.34B $0.28B 82.11%
2005-03-31 $0.34B $0.27B 81.79%
2004-12-31 $0.33B $0.26B 80.73%
2004-09-30 $0.31B $0.26B 81.21%
2004-06-30 $0.29B $0.24B 80.82%
2004-03-31 $0.28B $0.22B 80.36%
2003-12-31 $0.26B $0.21B 80.38%
2003-09-30 $0.22B $0.17B 77.23%
2003-06-30 $0.24B $0.18B 77.87%
2003-03-31 $0.25B $0.20B 78.71%
2002-12-31 $0.26B $0.21B 79.39%
2002-09-30 $0.26B $0.21B 78.71%
2002-06-30 $0.27B $0.21B 79.03%
2002-03-31 $0.27B $0.21B 78.97%
2001-12-31 $0.28B $0.22B 79.06%
2001-09-30 $0.32B $0.26B 81.82%
2001-06-30 $0.32B $0.26B 81.76%
2001-03-31 $0.32B $0.26B 81.96%
2000-12-31 $0.32B $0.26B 82.22%
2000-09-30 $0.31B $0.26B 82.26%
2000-06-30 $0.31B $0.25B 82.35%
2000-03-31 $0.30B $0.25B 82.21%
1999-12-31 $0.29B $0.24B 82.01%
1999-09-30 $0.29B $0.24B 82.23%
1999-06-30 $0.29B $0.24B 82.23%
1999-03-31 $0.29B $0.24B 82.53%
1998-12-31 $0.30B $0.24B 82.71%
1998-09-30 $0.30B $0.28B 93.56%
1998-06-30 $0.29B $0.24B 81.97%
1998-03-31 $0.29B $0.24B 81.60%
1997-12-31 $0.28B $0.24B 85.77%
1997-09-30 $0.27B $0.21B 78.10%
1997-06-30 $0.27B $0.25B 95.09%
1997-03-31 $0.26B $0.26B 100.00%
1996-12-31 $0.25B $0.25B 100.00%
1996-09-30 $0.24B $0.24B 100.00%
1996-06-30 $0.23B $0.23B 100.00%
1996-03-31 $0.22B $0.22B 100.00%
1995-12-31 $0.21B $0.21B 100.00%
1995-09-30 $0.20B $0.20B 100.00%
1995-06-30 $0.18B $0.18B 100.00%
1995-03-31 $0.17B $0.17B 100.00%
1994-12-31 $0.16B $0.16B 100.00%
1994-09-30 $0.15B $0.15B 100.00%
1994-06-30 $0.14B $0.14B 100.00%
1994-03-31 $0.13B $0.13B 100.00%
1993-12-31 $0.13B $0.13B 100.00%
1993-09-30 $0.12B $0.12B 100.00%
1993-06-30 $0.12B $0.12B 100.00%
1993-03-31 $0.11B $0.11B 100.00%
1992-12-31 $0.10B $0.10B 100.00%
1992-09-30 $0.09B $0.09B 100.00%
1992-06-30 $0.09B $0.09B 100.00%
1992-03-31 $0.08B $0.08B 100.00%
1991-12-31 $0.07B $0.07B 100.00%
1991-09-30 $0.07B $0.07B 100.00%
1991-06-30 $0.07B $0.07B 100.00%
1991-03-31 $0.06B $0.06B 100.00%
1990-12-31 $0.06B $0.06B 100.00%
1990-06-30 $0.04B $0.04B 100.00%
1990-03-31 $0.04B $0.04B 100.00%
1989-09-30 $0.05B $0.05B 100.00%
1989-03-31 $0.05B $0.05B 100.00%
1988-12-31 $0.05B $0.05B 100.00%
1988-09-30 $0.04B $0.04B 100.00%
1988-06-30 $0.04B $0.04B 100.00%
1988-03-31 $0.04B $0.04B 100.00%
1987-12-31 $0.04B $0.04B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.230B $0.480B
Nature's Sunshine Products manufactures and markets through direct sales encapsulated and tableted herbal products, high quality natural vitamins, and other complementary products. In addition to the United States, the Company has operations in Japan, Mexico, Central America, South Korea, Canada, Dominican Republic, Venezuela, Ecuador, Peru, the United Kingdom, Columbia, Brazil, Thailand, Israel, Singapore, Malaysia, Indonesia, the Philippines, Australia, Hong Kong, Taiwan, Russia, Ukraine, Latvia, Lithuania, Kazakhstan, Mongolia, Belarus, China, Poland, Germany, Austria, Norway, Sweden, the Czech Republic and the Netherlands. The Company also has exclusive distribution agreements with selected companies in Argentina, Australia, Chile, New Zealand, and Norway.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $68.396B 22.59
Takeda Pharmaceutical (TAK) Japan $59.919B 11.13
UCB SA (UCBJY) Belgium $45.739B 0.00
Otsuka Holdings, - (OTSKY) Japan $39.680B 14.84
BeOne Medicines - (ONC) Switzerland $38.041B 61.00
Sandoz Group AG (SDZNY) Switzerland $35.464B 0.00
Daiichi Sankyo, - (DSNKY) Japan $34.072B 21.27
Zoetis (ZTS) United States $30.343B 11.16
Astellas Pharma (ALPMY) Japan $26.892B 8.90
United Therapeutics (UTHR) United States $21.460B 17.90
Merck (MKKGY) Germany $19.487B 15.54
Shionogi (SGIOY) Japan $15.947B 9.37
IPSEN (IPSEY) France $15.395B 0.00
Neurocrine Biosciences (NBIX) United States $15.249B 20.72
Summit Therapeutics (SMMT) United States $13.881B 0.00
Orion OYJ (ORINY) Finland $12.984B 18.93
Madrigal Pharmaceuticals (MDGL) United States $12.089B 0.00
Corcept Therapeutics (CORT) United States $11.979B 263.86
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.965B 15.26
Crinetics Pharmaceuticals (CRNX) United States $9.013B 0.00
Eisai (ESAIY) $8.924B 0.00
Ionis Pharmaceuticals (IONS) United States $7.852B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.049B 13.27
Stevanato Group S.p.A (STVN) Italy $6.523B 32.64
Centessa Pharmaceuticals (CNTA) United Kingdom $6.267B 0.00
Oruka Therapeutics (ORKA) United States $6.105B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $5.317B 19.36
Grifols, S.A (GRFS) Spain $5.009B 0.00
Definium Therapeutics (DFTX) United States $4.947B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.923B 0.00
Relay Therapeutics (RLAY) United States $4.157B 0.00
Indivior Pharmaceuticals (INDV) United States $4.039B 9.38
Enliven Therapeutics (ELVN) United States $3.910B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.855B 11.93
Amylyx Pharmaceuticals (AMLX) United States $3.694B 0.00
Dyne Therapeutics (DYN) United States $3.343B 0.00
Hypermarcas (HYPMY) Brazil $3.203B 9.10
Soleno Therapeutics (SLNO) United States $2.717B 228.83
NewAmsterdam Pharma (NAMS) Netherlands $2.529B 0.00
Guardian Pharmacy Services (GRDN) United States $2.390B 45.28
Nektar Therapeutics (NKTR) United States $2.275B 0.00
Ocular Therapeutix (OCUL) United States $2.238B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.146B 15.81
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.085B 5.63
Xencor (XNCR) United States $1.766B 0.00
KARDIGAN INC (KARD) United States $1.735B 0.00
Xeris Biopharma Holdings (XERS) United States $1.366B 107.00
Harrow (HROW) United States $1.269B 0.00
Seaport Therapeutics (SPTX) United States $1.229B 0.00
Aktis Oncology (AKTS) United States $1.204B 0.00
Cronos Group (CRON) Canada $1.179B 29.09
Bioventus (BVS) United States $1.093B 17.10
Savara (SVRA) United States $1.081B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cybin (HELP) Canada $0.992B 0.00
Theravance Biopharma (TBPH) United States $0.885B 0.00
Avalo Therapeutics (AVTX) United States $0.862B 0.00
Ardelyx (ARDX) United States $0.847B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.821B 11.32
Esperion Therapeutics (ESPR) United States $0.819B 0.00
Aclaris Therapeutics (ACRS) United States $0.773B 0.00
Achieve Life Sciences (ACHV) Canada $0.753B 0.00
4D Molecular Therapeutics (FDMT) United States $0.753B 0.00
Silence Therapeutics (SLN) United Kingdom $0.750B 0.00
Apnimed (APMD) $0.711B 0.00
Collegium Pharmaceutical (COLL) United States $0.711B 3.13
Zevra Therapeutics (ZVRA) United States $0.692B 7.37
Ironwood Pharmaceuticals (IRWD) United States $0.671B 5.21
OmniAb (OABI) United States $0.630B 0.00
Altimmune (ALT) United States $0.628B 0.00
Aquestive Therapeutics (AQST) United States $0.604B 0.00
Evotec AG (EVO) Germany $0.580B 0.00
ProKidney (PROK) United States $0.526B 0.00
Indaptus Therapeutics (INDP) United States $0.485B 0.00
Relmada Therapeutics (RLMD) United States $0.474B 0.00
ARS Pharmaceuticals (SPRY) United States $0.423B 0.00
Larimar Therapeutics (LRMR) United States $0.406B 0.00
Prelude Therapeutics (PRLD) United States $0.361B 0.00
Century Therapeutics (IPSC) United States $0.359B 0.00
Lexeo Therapeutics (LXEO) United States $0.339B 0.00
Inhibikase Therapeutics (IKT) United States $0.322B 0.00
Avita Medical (RCEL) United States $0.314B 0.00
Pyxis Oncology (PYXS) United States $0.278B 0.00
USANA Health Sciences (USNA) United States $0.275B 15.05
Elite Pharmaceuticals (ELTP) United States $0.268B 12.44
Lyell Immunopharma (LYEL) United States $0.267B 0.00
Akebia Therapeutics (AKBA) United States $0.250B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
AleAnna (ANNA) United States $0.226B 17.84
Protara Therapeutics (TARA) United States $0.222B 0.00
Cardiol Therapeutics (CRDL) Canada $0.215B 0.00
Siga Technologies (SIGA) United States $0.214B 0.00
Journey Medical (DERM) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.208B 0.00
Korro Bio (KRRO) United States $0.207B 0.00
Surrozen (SRZN) United States $0.206B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.199B 0.00
Organogenesis (ORGO) United States $0.188B 0.00
Minerva Neurosciences (NERV) United States $0.183B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Atrium Therapeutics (RNA) United States $0.173B 0.00
NRx Pharmaceuticals (NRXP) United States $0.147B 0.00
Innate Pharma SA (IPHYF) France $0.138B 0.00
Unicycive Therapeutics (UNCY) United States $0.131B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.129B 0.00
VAXART, INC (VXRT) United States $0.117B 3.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Rafael Holdings (RFL) United States $0.111B 0.00
Vivani Medical (VANI) United States $0.111B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 0.00
PolyPid (PYPD) Israel $0.098B 0.00
HST Global (HSTC) United States $0.092B 0.00
ElectroCore (ECOR) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Nutriband (NTRB) United States $0.083B 0.00
Aldeyra Therapeutics (ALDX) United States $0.083B 0.00
Telomir Pharmaceuticals (TELO) United States $0.080B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Acrivon Therapeutics (ACRV) United States $0.078B 0.00
Gain Therapeutics (GANX) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Talphera (TLPH) United States $0.062B 0.00
Nuo Therapeutics (AURX) $0.061B 0.00
Heron Therapeutics (HRTX) United States $0.060B 0.00
Dominari Holdings (DOMH) United States $0.053B 0.00
Veraxa Biotech AG (VRXA) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
Incannex Healthcare (IXHL) Australia $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Context Therapeutics (CNTX) United States $0.033B 0.00
Optimi Health (OPTH) Canada $0.029B 0.00
Cosmos Health (COSM) United States $0.028B 0.00
TransCode Therapeutics (RNAZ) United States $0.027B 0.00
Plus Therapeutics (PSTV) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Universe Pharmaceuticals INC (UPC) China $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Enlivex (ENLV) Israel $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Vyome Holdings (HIND) United States $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
Natural Alternatives (NAII) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Xenetic Biosciences (XBIO) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Wellgistics Health (WGRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.007B 0.00
Ernexa Therapeutics (ERNA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Liminatus Pharma (LIMN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Niki BioSolutions (NIKI) United Kingdom $0.004B 0.00
Nuvilex (PMCB) United States $0.004B 0.00
Addex Therapeutics (ADXN) Switzerland $0.004B 0.00
Galmed Pharmaceuticals (EOCN) Israel $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Jupiter Neurosciences (JUNS) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Vivos Therapeutics (VVOS) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Clearmind Medicine (CMND) Canada $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00